Treatment with inebilizumab is significantly effective and safe for patients with AChR+ or MuSK+ generalized myasthenia ...

Women and racial-ethnic minorities remain underrepresented in academic neurology, especially in higher ranks and leadership ...

The use of oral edaravone for a total of 144 weeks is safe and well-tolerated among patients with amyotrophic lateral ...

Neurophobia among Hispanic medical students may deter them from choosing neurology, potentially leading to a future shortage ...

ZYN002 is safe and effectively reduces irritability-related behavioral symptoms in children and adolescents with fragile X ...

Patients who take foslevodopa/foscarbidopa who wake in the "ON" state show improved motor function, daily activities, and ...

Over the last 2 decades, aspiration pneumonia and Alzheimer disease-related mortality have significantly decreased in older ...

Fremanezumab is safe, effective, and tolerable for children and adolescents with episodic migraine, reducing monthly migraine ...

Among patients with narcolepsy, AXS-12 (reboxetine) vs placebo significantly reduced the frequency of cataplexy attacks.

Early CPAP treatment for individuals with OSA may help reduce the onset of Parkinson disease and other neurodegenerative ...

Hypertension-related vascular dementia mortality rates have increased over the past 15 years, especially among Black and African American individuals.

Oral carbidopa-levodopa formulation improves sleep in Parkinson disease, particularly addressing sleep disturbances and ...